Vanguard Pharma Achieves Record 2014 Financial Results, Poised for Strong 2015 Growth
March 30, 2015 04:23 PM
Vanguard Pharma has announced record-breaking financial results for the full 2014 fiscal year.
Kevin Danylchuk, President & General Manager, commented, "I am pleased to announce that Vanguard executed very successfully on corporate objectives to grow company revenues, to offer a wider variety of selling models for our clients, and to broaden our client base across our U.S. and Canadian businesses. As we begin the 2nd quarter of 2015, Vanguard is performing at record levels for a variety of key metrics including annual revenue (2014), quarterly revenue (projected 1st quarter 2015), number of active clients, number of project renewals, number of sales representatives, and number of total employees."
Additionally, Mr. Danylchuk reported that Vanguard Pharma is enthusiastically engaging in partnerships in many different areas of health care — not just pharmaceuticals. Examples of recent sales programs for Vanguard's clients involve diagnostic tests, genetic (personalized) medicine, nutrition education and capital equipment sales. "We could not be more excited about the future, and we look forward to the 2nd quarter of 2015 and beyond," he added.